Wall Street Jedi
  • About us
  • Contact us
  • Privacy Policy
  • Terms & Conditions
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
No Result
View All Result
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
No Result
View All Result
Wall Street Jedi
No Result
View All Result
Home Investing

Masimo smartwatches infringe Apple design patents, US jury says

by
October 25, 2024
in Investing
0
Masimo smartwatches infringe Apple design patents, US jury says
0
SHARES
3
VIEWS
Share on FacebookShare on Twitter

By Blake Brittain

(Reuters) -Apple convinced a federal jury on Friday that health monitoring tech company Masimo (NASDAQ:MASI)’s smartwatches infringe two of its design patents.

The jury, in Delaware, agreed with Apple (NASDAQ:AAPL) that Masimo’s W1 and Freedom watches and chargers willfully violated Apple’s patent rights in smartwatch designs, awarding the tech giant $250 in damages. Apple’s attorneys told the court the “ultimate purpose” of its lawsuit was to win an injunction against sales of Masimo’s smartwatches after an infringement ruling.

The jury also determined that Masimo’s watches did not infringe Apple patents covering smartwatch inventions that the tech giant had accused Masimo of copying.

Masimo said in a statement that the company appreciated the jury’s verdict “in favor of Masimo and against Apple on nearly all issues,” and that the decision only applied to a “discontinued module and charger.”

“Apple primarily sought an injunction against Masimo’s current products, and the jury’s verdict is a victory for Masimo on that issue,” Masimo said.

Apple said in a statement that it was “glad the jury’s decision today will protect the innovations we advance on behalf of our customers.”

Irvine, California-based Masimo accused Apple of hiring away its employees and stealing its pulse oximetry technology after discussing a potential collaboration. Masimo convinced the U.S. International Trade Commission last year to block imports of Apple’s Series 9 and Ultra 2 smartwatches after the commission found that their technology for reading blood oxygen levels infringed Masimo’s patents.

Apple has appealed the decision and resumed selling the watches after removing the technology. The tech giant countersued Masimo for patent infringement in 2022, alleging that Masimo copied Apple Watch features to use in its smartwatches.

Apple also accused Masimo of using lawsuits at the ITC and in California to “make way for Masimo’s own watch.” Masimo said Apple’s patent lawsuit was “retaliatory” and “an attempt to avoid the court in which the parties have been litigating their dispute.”

This post appeared first on investing.com
Previous Post

Earnings call: HCA Healthcare reports robust Q3 growth despite hurricanes

Next Post

Moody’s lowers France’s outlook on budget fears, maintains rating

Next Post
Moody’s lowers France’s outlook on budget fears, maintains rating

Moody’s lowers France’s outlook on budget fears, maintains rating

  • Trending
  • Comments
  • Latest
American creating deepfakes targeting Harris works with Russian intel, documents show

American creating deepfakes targeting Harris works with Russian intel, documents show

October 23, 2024
Cadence raises midpoint of 2024 profit forecast on robust demand from chip designers

Cadence raises midpoint of 2024 profit forecast on robust demand from chip designers

October 28, 2024
Israel stocks lower at close of trade; TA 35 down 0.23%

Israel stocks lower at close of trade; TA 35 down 0.23%

October 6, 2024
Takeaways from the start of a Fed rate-cutting cycle

Takeaways from the start of a Fed rate-cutting cycle

October 12, 2024
Krispy Kreme stock plunges after doughnut chain pauses McDonald’s rollout, pulls outlook

Krispy Kreme stock plunges after doughnut chain pauses McDonald’s rollout, pulls outlook

0
Retailers scramble to move billions in cargo as East Coast dockworkers prepare to strike

Retailers scramble to move billions in cargo as East Coast dockworkers prepare to strike

0
PepsiCo to buy tortilla chip maker Siete Foods for $1.2 billion

PepsiCo to buy tortilla chip maker Siete Foods for $1.2 billion

0
East and Gulf coast ports shut down as thousands of workers go on strike

East and Gulf coast ports shut down as thousands of workers go on strike

0
Krispy Kreme stock plunges after doughnut chain pauses McDonald’s rollout, pulls outlook

Krispy Kreme stock plunges after doughnut chain pauses McDonald’s rollout, pulls outlook

May 8, 2025
UnitedHealthcare sued by shareholders over reaction to CEO’s killing

UnitedHealthcare sued by shareholders over reaction to CEO’s killing

May 8, 2025
NBA star Russell Westbrook launches AI-enabled funeral planning startup

NBA star Russell Westbrook launches AI-enabled funeral planning startup

May 7, 2025
AMD CEO calls China a ‘large opportunity’ and warns against strict U.S. chip controls

AMD CEO calls China a ‘large opportunity’ and warns against strict U.S. chip controls

May 7, 2025

Recent News

Krispy Kreme stock plunges after doughnut chain pauses McDonald’s rollout, pulls outlook

Krispy Kreme stock plunges after doughnut chain pauses McDonald’s rollout, pulls outlook

May 8, 2025
UnitedHealthcare sued by shareholders over reaction to CEO’s killing

UnitedHealthcare sued by shareholders over reaction to CEO’s killing

May 8, 2025
NBA star Russell Westbrook launches AI-enabled funeral planning startup

NBA star Russell Westbrook launches AI-enabled funeral planning startup

May 7, 2025
AMD CEO calls China a ‘large opportunity’ and warns against strict U.S. chip controls

AMD CEO calls China a ‘large opportunity’ and warns against strict U.S. chip controls

May 7, 2025

Disclaimer: WallStreetJedi.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

  • About us
  • Contact us
  • Privacy Policy
  • Terms & Conditions

Copyright © 2025 wallstreetjedi.com | All Rights Reserved

No Result
View All Result
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock

Copyright © 2025 wallstreetjedi.com | All Rights Reserved